CONFERENCE OVERVIEW This conference focuses on the most current topics affecting the diagnosis and treatment of breast diseases, and aims to provide the audience with information that updates and describes the current and future care of breast disorders. This educational experience will provide the participants with elements relevant to their daily practice, and will assist them in recognizing the alternatives of diagnosis and therapy available now and in the near future. The program includes discussions on genetics, radiology issues, breast imaging, stem cells and biomaterials, and immunotherapy. All the experts will participate in an interactive session of questions and answers open to the audience. This half-day session will be useful to surgeons, gynecologists, family practitioners, internists, residents, medical students, nurses, nuclear medicine personnel, and radiology and ultrasonography technologists. OBJECTIVES At the close of this symposium, participants should be able to: ? Describe the future of breast imaging ? Enumerate specific genetic risks beyond BRCA testing ? Cite modern techniques for breast reconstruction ? Understand the future diagnosis of breast cancer ? Describe immunotherapy for breast cancer • And other relevant topics

It is the policy of the CAMC Health Education and Research Institute that any faculty (speaker) who makes a presentation at a program designated for AMA Physician’s Recognition Award (PRA) Category I or II must disclose any financial interest or other relationship; (i.e. spouses/partners, grants, research support, consultant, honoraria) that faculty member has with the manufacturer(s) of any commercial product(s) that may be disclosed in the educational presentation. Program Planning Committee Members must also disclose any financial interest or relationship with commercial industry that may influence their participation in this conference. Faculty relationships with industry, if any, will be made available on-site and disclosure made from the podium to the participants